Answers are grounded in this paper and cite their sources.
Pancreatic ductal adenocarcinoma (PDAC) exhibits invasive growth and resistance to gemcitabine. We investigated how the actin-binding protein ACTN4 connects invasive behavior with WNT/β-catenin signaling. Elevated ACTN4 expression was associated with poorer survival in public PDAC cohorts and metastatic disease in genetically engineered mice. ACTN4 depletion reduced TGF-β1-induced invasion, focal adhesion signaling, and WNT activity, while increasing gemcitabine sensitivity in cells and organoids. Biochemical analyses and genetic rescue experiments linked Ser159-dependent ACTN4 activity to HDAC7 stability, reduced DACT2 expression, and β-catenin-dependent transcription. DACT2 depletion partially reversed the effects of ACTN4 loss. Ellagic acid reduced ACTN4-HDAC7 complex recovery and attenuated associated signaling. These findings support a functional model connecting ACTN4 to HDAC7-DACT2 regulation and identify an ACTN4-associated signaling axis relevant to PDAC invasion and gemcitabine response.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: